High-Intensity Intravenous Cyclophosphamide and Cisplatin, Interim Surgical Debulking, and Intraperitoneal Cisplatin in Advanced Ovarian Carcinoma: A Pilot Trial with Ten-Year Follow-up

By Shapiro F.   Schneider J.   Markman M.   Reichman B.S.   Venkatraman E.   Barakat R.   Almadrones L.   Spriggs D.  

Gynecologic Oncology, Vol. 67, Iss. 1, 1997-10 ,pp. : 39-45

Elsevier

Access to resources Recommend Favorite

Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients - 10-year results of a prospective randomised phase III study comparing carboplatin-cisplatin with cyclophosphamide-cisplatin

By Dittrich C.   Sevelda P.   Salzer H.   Obermair A.   Speiser P.   Breitenecker G.   Schemper M.   Kaider A.   on behalf of the Austrian Ovarian Cancer Study Group  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1129-1140

Elsevier

Access to resources Recommend Favorite

Cisplatin-Paclitaxel-Cyclophosphamide with G-CSF in Primary Advanced Epithelial Ovarian Cancer

By Fanning J.   Colgrove M.   Phibbs G.  

Gynecologic Oncology, Vol. 79, Iss. 1, 2000-10 ,pp. : 97-100

Elsevier

Access to resources Recommend Favorite

Ten year results of a randomised trial comparing two conservative treatment strategies for small size breast cancer

By Mariani L.   Salvadori B.   Marubini E.   Conti A.R.   Rovini D.   Cusumano F.   Rosolin T.   Andreola S.   Zucali R.   Rilke F.   Veronesi U.  

European Journal of Cancer, Vol. 34, Iss. 8, 1998-07 ,pp. : 1156-1162

Elsevier

Access to resources Recommend Favorite

Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective

By Berger K.   Fischer T.   Szucs T.D.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1894-1901

Elsevier

Access to resources Recommend Favorite